Perioperative cardiac dysrhythmias: Diagnosis and management

Anesthesiology

Volumn 86, Issue 6, 1997, Pages

  Atlee, John L ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Equipment: pacemaker; Heart: bradycardia; tachycardia; dysrhythmias; artificial pacing; Pharmacology: antidysrhythmics; calcium channel blockers; beta blockers

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; EDROPHONIUM; ESMOLOL; GLYCOPYRRONIUM BROMIDE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MAGNESIUM SULFATE; METOPROLOL; PHENYTOIN; POTASSIUM CHLORIDE; PROCAINAMIDE; PROPRANOLOL; VERAPAMIL;

ANESTHESIA COMPLICATION; ANTIARRHYTHMIC ACTIVITY; BRONCHOSPASM; CARDIOTOXICITY; CARDIOVERSION; CLINICAL FEATURE; DRUG CHOICE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART PACING; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SINUS NODE DISEASE; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TORSADE DES POINTES;

EID: 0030962655     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199706000-00026     Document Type: Review

References (290)

1. Katz R, Bigger J: Cardiac arrhythmias during anesthesia and operation. ANESTHESTOLOGY 1970; 33:193-213
2. Atlee J, Bosnjak Z: Mechanisms for cardiac dysrhythmias during anesthesia. ANESTHESIOLOGY 1990; 72:347-74
3. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrthythmogenic mechanisms. Circulation 1991; 84:1831-51
4. Janse M, Wit A: Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infraction. Physiol Rev 1989; 69:1049-169
5. Marinchak R, Rials S: Tachycardias in the Wolff-Parkinson-White syndrome including atrioventricular reciprocating tachycardia, atrial flutter, and atrial fibrillation, cardiac Arrhythmia. Edited by Podrid P, Kowey P. Baltimore, Williams and Wilkins, 1995, pp 847-74
6. Morganroth J: Proarrhythmic effects of antiarrhythmic drugs: evolving concepts. Am Heart J 1992; 123:1137-9
7. Moss A, Zareba W, Robinson J: The long QT syndrome, Cardiol Rev 1995; 3:79-85
8. Wellens H, Rodriguez L-M, Smeets J: Ventricular tachycardia in structurally normal hearts, Cardiac Electrophysiology, 2nd ed. Edited by Zipes D, Jalife J. Philadelphia, WB Saunders, 1995. pp 780-8
9. Zipes D, Jalife J: Cardic Electrophysiology: From Cell to Bedside, 2nd ed. Philadelphia, WB Saunders, 1995. pp 467-606
10. Gettes L: Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation 1992; 85:70-6
11. Gottlieb S, Fisher M, Pressel M, Patten R, Weinberg R, Greenberg N: Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure. Am Heart J 1993; 125:1645-50
12. Iseri L, Allen B, Ginkel M: Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 1992; 123:1404-9
13. Kerin N, Somberg J: Proarrhythmia: Definition, risk factors, causes, treatment, and controversies. Am Heart J 1994; 128:575-86
14. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT, and the Ibutilide repeat dose study Investigators: Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996; 94:1613-21
15. De Luna A, Guindo J, Vinolas X, Bayes-Genes A, Sobral J, Sztajzel J, Boveda S: Proarrhythmic effects of anti-arrhythmic agents. Postgrad Med J 1994; 70:S84-8
16. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainde on mortality in a randomized trial of arrhythmia suppression after myocardial infraction. N Engl J Med 1989; 321:406-12
17. The Cardiac Arrhythmia Suppression Trial (CAST) Inevstigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327:227-33
18. Martyn R, Somberg J, Kerin N: Proarrhythmia of nonantiarrhythmic drugs. Am Heart J 1993; 126:202-5
19. Podrid P, Fogel R: Aggravation of arrhythmia by antiarrhythmic drugs, and the important role of underlying ischemia. Am J Cardiol 1992; 70:100-2
20. Starmer C, Romashko D, Reddy R, Zilberter Y, Starobin J, Grant A, Krinsky V: Proarrhythmic response to potassium channel blockade. Circulation 1995; 92:595-605
21. Benson DJ: Transesophageal pacing and electrocardiography in the neonate. Diagnostic and therapeutic uses. Clin Perinatol 1988; 15:619-50
22. Birktui P, Trigano J, Zoll P, eds: Noninvasive Transcutaneous Cardiac Pacing. Mt. Kisco, NY, Futura Publishing, 1993, pp 1-228
23. Ross R: Esophageal electrograms and pacing for cardiac arrhythmias, Cardiac Arrhythmia. Edited by Podrid P, Kowvey P. Baltimore, Williams and Wilkins, 1995, 312-22
24. Zipes D, Jalife J: Cardiac Electrophysiology: From Cell to Bedside, 2nd ed. Philadelphia, WB Saunders, 1995, pp 1453-99, 1502-37, 1547-83
25. Atlee J: Arrhythmias and Pacemakers, Philadelphia, WB Saunders, 1996, 205-46, 293-329
26. Kusumoto F, Goldschlager N: Cardiac pacing. N Engl J Med 1996; 334:89-98
27. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach. Armonk, NY, Futura Publishing, 1994, pp 121-248
28. Forrest J, Cahalan M, Rehder K, Goldsmith C, Levy R, Strunin L, Bota W, Bouchek C, Bucchiara R, Dhamee M, Domino K, Dudman A, Hamilton W, Kampine J, Kotrly K, Maltby J, Mazloomdoost M, MacKenzie R, Melnick B, Motoyama E, Muir J, Munshi C: Multicenter study of general anesthesia. II. Results. ANESTHESIOLOGY 1990; 72:262-8
29. Forrest J, Rehder K, Cahalan M, Goldsmith C: Multicenter study of general anesthesia III. Predictors of severe perioperative adverse outcomes. ANESTHESIOLOGY 1992; 76:3-15
30. Steinbach K, Merl O, Frohner K, Hief C, Nürnberg M, Kaltenbrunner W, Podczeck A, Wessely E: Hemodynamics during ventricular tachyarrhythmias. Am Heart J 1994; 127:1102-6
31. Zipes D: Specific arrhythmias: Diagnosis and treatment, Heart Disease, 4th ed. Edited by Braunwald E. Philadelphia, WB Saunders, 1992, pp 667-725
32. Fenelon G, Wigjns W, Andries E, Brugada P: Tachycardiomyopathy: Mechanisms and clinical implications. PACE: 1996; 19:95-106
33. Gottlieb S: Hemodynamic effects of arrhythmia and antiarrhythmic agents, Cardiac Arrhythmia. Edited by Podrid P, Kowey P. Baltimore, Williams and Wilkins, 1995, 739-51
34. Baig M, Perrins C: The hemodynamics of cardiac pacing. Prog Cardiovasc Dis 1991; 33:283-98
35. Brutsaert D, Sys S, Gillbert T: Diastolic failure: Pathophysiology and therapeutic implications. J Am Coll Cardiol 1993; 22:318-25
36. Dean J, Poole-Wilson P: Therapeutic implications of diastolic dysfunction in heart failure. Postgrad Med J 1990; 66:932-7
37. Packer M: Abnormalities of diastolic function as a [potential cause of exercise intolerance in heart failure. Circulation 1980; 81(Supp1 III):78-86
38. Atlee J, Pattison C, Mathews E, Hedman A: Transesophageal atrial pacing for intraoperative sinus bradycardia or AV junctional rhythm: Feasibility as prophylaxis in 200 anesthetized adults and hemodynamic effects of treatment. J Cardiothorac Vase Anesth 1993; 7:436-41
39. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, pp 25-104
40. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach. Armonk, NY, Futura Publishing, 1994, pp 211-27
41. Myerburg R, Kessler K, Castellanos A: Sudden cardiac death: Structure, function, and time-dependence of risk. Circulation 1992; 85(Suppl I):I-2-I-10
42. Myerburg R, Kessler K, Kimura S, Castellanos A: Sudden cardiac death: Future approaches based on identification and control of transient risk factors. J Cardiovasc Electrophysiol 1992; 3:626-40
43. Vicenzi M, Woehlck H, Bosnjak Z, Atlee J: Anesthetics and automaticity of dominant and latent pacemakers in chronically instrumented dogs. II. Effects of enflurane and isoflurane during exposure to epinephrine with and without muscarinic blockade. ANESTHESIOLOGY 1993; 79:1316-23
44. Atlee J: Perioperative Cardiac Dysrhythmias. Chicago, Year Book Medical Publishers, 1990, 373-424
45. Wagner G: Marriott's Practical Electrocardiography, 9th ed. Baltimore, Williams and Wilkins, 1994, pp 309-32
46. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, 336-62
47. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 262-300
48. Hayes D, Holmes D: Temporary cardiac pacing, A Practice of Cardiac Pacing. 3rd ed. Edited by Furman S, Hayes D, Holmes D. Mt. Kisco, NY, Futura Publishing, 1993, pp 231-60
49. Benson D: Transesophageal electrocardiography and cardiac pacing. State of the art. Circulation 1987; 75(Suppl III):86-90
50. Wagner G: Marriott's Practical Electrocardiography, 9th ed. Baltimore, Williams and Wilkins, 1994, pp 197-226
51. Wagner G: Marriott's Practical Electrocardiography, 9th ed. Baltimore, Williams and Wilkins, 1994, pp 336-66
52. Grant A: On the mechanism of action of antiarrhythmic agents. Am Heart J 1992; 123:1130-6
53. Nattel S: Comparative mechanisms of action of antiarrhythmic drug. Am J Cardiol 1993; 72:13F-7F
54. Reiffel J, Correia J: "In the absence of structural heart disease . . ." What is it, and why does it matter in antiarrhythmic therapy? Am Heart J 1994; 128:626-9
55. Singh B: Controlling cardiac arrhythmias by lengthening repolarization: Historical overview. Am Heart J 1993; 72:18F-24F
56. Whalley D, Wendt D, Grant A: Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs. PACE 1995; 18:1686-704
57. Whalley D, Wendt D, Grant A: Basic concepts in cellular cardiac elcctrophysiology: Part I: Ion channels, membrane currents, and the action potential, PACE 1995; 18:1556-74
58. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis. 1994:347-91
59. Fazekas T, Scherlag B, Mabo P, Patterson E, Lazzara R: Facilitation of reentry by lidocaine in canine myocardial infarction. Am Heart J 1994; 127:345-52
60. Vaughan Williams E: Classification of antiarrhythmic drugs, Cardiac Arrhythmias. Edited by Sandoe E, Flensted-Jensen E, Olesen K. Sodertaljie, Sweden: AB Astra, 1971, pp 449-72
61. Harrison D, Winkle R, Sami M, Mason J: Encainide: a new and potent antiarrhythmic agent, Cardiac Arrhythmias: A Decade of Progress. Edited by Harrison D. Boston, GK Hall, 1981, pp 315-30
62. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, pp 154-204
63. Roden D: Antiarrhythmic drugs, Goodman and Gilman's The Pharmacologic Basis of Therapeutics. 9th ed. Edited by Hardman J, Limbird L. New York, McGraw-Hill, 1996, pp 839-74
64. Zipes D: Management of cardiac arrhythmias: Pharmacological, electrical, and surgical techniques, Heart Disease, 4th ed. Edited by Braunwald E. Philadelphia, WB Saunders, 1992, pp 628-66
65. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach. Armonk, NY, Futura Publishing, 1994, pp 85-101
66. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 391-404
67. McDonald T, Courtney K, Clusin W: Use-dependent block of single sodium channels by lidocaine in guinea pig ventricular myocytes. Biophys J 1989; 55:1261-77
68. Hondeghem L, Katzung B: Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol 1984; 24:387-423
69. Arnsdorf M, Bigger JJ: Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers. J Clin Invest 1972; 51:2252-63
70. Wang Z, Pelletier L, Talajic M, Nattel S: Effects of flecainide and quinidine on human atrial action potentials. Role of rate-depen- dence and comparison with guinea pig, rabbit, and dog tissues. Circulation 1990; 82:274-83
71. Bay es de Luna A, Coumel P, Leclercq J: Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117-9
72. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, 404-21
73. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach, Armonk, NY, Futura Publishing, 1994, pp 41-84
74. Anderson J, Gilbert E, Alpert B, Henthorn R, Waldo A, Bhandari A, Hawkinson R, Pritchett E: Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter, double-blind, crossover study of flecainde and placebo with transtelephonic monitoring. Circulation 1989; 80: 1555-70
75. Henthorn R, Waldo A, Anderson J, Gilbert E, Alpert B, Bhandari A, Hawkinson R, Pritchett E, and the Flecainide Supraventricular Tachycardia Study Group: Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. Circulation 1991; 83:119-25
76. Funck-Bretano C, Kroemer H, Lee J, Roden D: Drug therapy: propafenone. N Engl J Med 1990; 322:518-25
77. McLeod A, Stiles G, Shand D: Demonstration of beta adrenoreceptor blockade by propafenone hydrochloride: Clinical pharmacologic, radioligand binding and adenylate cyclase activation studies. J Pharmacol Exp Ther 1984; 228:461-6
78. Muller-Peltzer H, Greger C, Neugebauer G, Hollmann M: Beta-blocking and electrophysiologic effects of propafenone in volunteers. Eur J Clin Pharmacol 1983; 25:851-3
79. Valenzuela C, Delgado C, Tamargo J: Electrophysiologic effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers. J Cardiovasc Pharmacol 1987; 18: 911-7
80. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp. 421-34
81. Katritsis D, Butrous G, Camm A: Three decades of antiarrhythmic therapy. PACE 1992; 15:1394-402
82. Podrid P, Kowey P: Cardiac Arrhythmia, Baltimore, Williams and Wilkins, 1995, pp 450-66
83. Hoffman B, Lefkowitz R: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, Goodman and Gilman's The Pharmacologic Basis of Therapeutics. Edited by Hardman J, Limbird L. New York, McGraw-Hill, 1996, 199-248
84. Nonwegian Multicenter Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304:801-7
85. Beta Blockcr Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. Part I. Mortality results. JAMA 1981; 247:1707-14
86. Australian and Swedish Pindolol Study Group: The effect of pindolol on two year mortality after complicated myocardial infarction Eur Heart J 1983; 4:36-75
87. Kowy P, Levine J, Herre J, Pacifico A, Lindsay B, Plumb V, Janosik D, Kopelman H, Scheinman M: Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation 1995; 92:3255-63
88. Podrid P, Kowey P: Cardiac Arrhythmia, Baltimore, Williams and Wilkins, 1995, pp 434-49
89. Burkart F, Pifsterer M, Kiowski W, Follath F, Burckhardt D, Jordi H: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct survival (BASIS). J Am Coll Cardiol 1990; 16:1711-8
90. Nicklas J, McKenna W, Stewart R, Mickelson J, Das S, Schork M, Krikler S, Quain L, Morady F, Pitt B: Prospective, double-blind, placebo-controlled trial of low dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991; 122:1016-21
91. Pflisterer M, Kiowski W, Brunner H, Burckhardt D, Burkart F: Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 1993; 87:309-11
92. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, 25-104
93. Cote P, Bourassa M, Delay J, Janin A, Froment R, David P: Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation 1979; 59:1165-72
94. Gallagher J, Lieberman R, Meranze J, Spielman S, Ellison N: Amiodarone-induced complications during coronary surgery. ANESTHESIOLOGY 1981; 55:186-8
95. McKinnon G, Landymore R, Marble A: Should oral amiodarone he used for sustained ventricular tachycardia in patients requiring open heart surgery? Can J Surg 1983; 26:355-7
96. Navalgund A, Alifimoff J, Jajymec A, Bleyaert A: Amiodarone-induced sinus arrest successfully treated with ephedrine and isoproterenolol. Anesth Analg 1986; 65:-414-6
97. Levine J, Massumi A, Scheinman M, Winkle R, Platia E, Chilson D, Gomes A, Woosley R: Intravenous amiodarone for recurrent sustained hypotensive ventricular tachydysrhythmias. J Am Coll Cardiol 1996; 27:67-75
98. Donovan KD Dobb JG, Coombs LJ, Lee K-Y, Weekes JN, Murdock CJ, Clarke GM: Efficacy of flecainide for the reversion of acute onset atrial fibrillation. Am J Cardiol 1992; 70:50A-5
99. Bianconi L, Boccadamo R, Pappalardo A, Gentili C, Pistolese M: Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989; 64:335-8
100. Galve E, Rius T, Ballester R, Artaza MA, Arnau JM, Garcia-Dorado D, Soler-Soler, J: Intravenous amiodarooe in treatment of recent-onset atrial fibrillation: Results of a randomized controlled study. J Am Coll Cardiol 1996; 27:1079-82
101. Emergency Care Committee and Subcommittees AHA: Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Part III. Adult advanced cardiac life support. JAMA 1992; 268:2199-241
102. Claudel J, Touboul P: Sotalol: From "just" another beta blocker to "the prototype of class 3 antidysrhythmic compound. PACE 1995; 18:-451-67
103. Hohnloser S, Zabel M, Krause T, Just H: Short- and long-term antiarrhythmic and hemodynamic effects of d, 1 sotalol in patients with symptomatic ventricular arrhythmias Am Heart J 1992; 123:1220-4
104. Singh B: Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents. Am J Cardiol 1993; 72:8A-18A
105. Samoil D, Grubb B, Temsey-Armos P: Sotalol: A new agent for treatment of ventricular arrhythmias Am J Med Sci 1994; 307:49-53
106. Twidale N, Roberts-Thomson P, McRitchie R: Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol. Am Heart J 1993; 126:122-9
107. Campbell T, Gavaghan T, Morgan J: Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Br Heart J 1985; 54:86-90
108. Janssen J, Loomans L, Harink J, Taams M, Brunninkhuis L, Van der Starre P, Koostra G: Prevention and treatment of supraventricular tachycardia shortly after coronary bypass grafting: A randomized open trial. Angiology 1986; 37:601-9
109. Jacquet L, Evenepoel M, Marenne F, Evrard P, Verhelst R, Dion R, Goenen M: Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary bypass surgery. J Cardiothor Vasc Anesth 1994; 8:431-6
110. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 466-78
111. Robertson R, Robertson D: Drugs used for the treatment of myocardial ischemia, Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 9th ed. Edited by Hardman J, Limbird L. New York, McGraw-Hill, 1996, pp 759-79
112. Levine J, Michael J, Guarnieri T: Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985; 312:21-5
113. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, 25-104, 262-96
114. Atlee J, Hamann S, Brownlee S, Kreigh C: Conscious state-comparisons of the effects of the inhalation anesthetics and diltiazem, nifedipine, or verapamil on specialized atrioventricular conduction times in spontaneously beating dog hearts. ANESTHESIOLOGY 1988; 68:519-28
115. Atlee J, Bosnjak Z, Yeager T: Effects of diltiazem, verapamil and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs. ANESTHESIOLOGY 1990; 72:889-901
116. Chelly J, Rogers K, Hysing E, Taylor A, Hartley C, Merin R: Cardiovascular effects of interactions between calcium channel blocking drugs and anesthetics in chronically instrumented dogs. I. Verapamil and halothane. ANESTHESIOLOGY 1986; 64:560-7
117. Kapur P, Bloor B, Flacke W, Olewine S: Comparison of cardiovascular responses to verapamil during enflurane, isoflurane, or halothane anesthesia in the dog. ANESTHESIOLOGY 1984; 61:156-60
118. Priebe H, Sharvan K: Cardiovascular and electrophysiologic interactions between diltiazem and isoflurane in the dog. ANESTHESIOLOGY 1987; 66:111-21
119. Freilich A, Tepper D: Adenosine and its cardiovascular effects. Am Heart J 1992; 123:132-1-8
120. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 488-98
121. Camm A, Garrat C: Adenosine and supraventricular tachycardia. N Engl J Med 1991; 325:1621-9
122. Drew B, Scheinman M: EGG criteria to distinguish between aberrantly conducted supraventricular tachycardia: Practical aspects for the immediate care setting. PACE 1995; 18:2191-208
123. Barold S: Bedside diagnosis of wide QRS tachycardia. PACE 1995; 18:2109-15
124. Crossen J, Etheridge S, Milstein S, Hesslein P, Dunnigan A: Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 1994; 74:155-60
125. Brodsky M, Hwang C, Hunter D, Chen P, Smith D, Ariani M, Johnston W, Allen B, Chun J, Gold C: Life-threatening alterations in heart rate after the use of adenosine in atrial flutter. Am Heart J 1995; 130:56-71
126. Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S: Adenosine induced torsades de pointes in a child with congenital lung QT syndrome. PACE 1994:1814-7
127. McIntosh-Yellin N, Drew B, Scheinman M: Safety and efficacy of central intravenous bolus administration of adenosine for termination of supraventricular tachycardia. J Am Coll Cardiol 1993; 22:741-5
128. Seller R: The role of magnesium in digitalis toxicity. Am Heart J 1971; 82:551-6
129. Smith T, Braunwald E, Kelly R: The management of heart failure, Heart Disease, 4th ed. Edited by Braunwald E. Philadelphia, WB Saunders, 1992, pp 464-519
130. Brown J, Taylor P: Muscarinic receptor agonists and antagonists, Goodman and Gilman's The Pharmacologic Basis of Medical Therapeutics, 9th ed. Edited by Hardman J, Limbird L. New York, McGraw-Hill, 1996, pp 141-60
131. Palmisano B, Setlock M, Brown M, Siker D, Tipuraneni R: Dose-response for atropine and heart rate in infants and children anesthetized with halothane and nitrous oxide. ANESTHESIOLOGY 1991; 75:238-42
132. Frieden J, Cooper J, Grossman J: Continuous infusion of edrophonium (Tensilon) in the treatment of supraventricular tachycardia. Am J Cardiol 1971; 27:294-7
133. Moss A, Aledort L: Use of edrophonium (Tensilon) in the evaluation of supraventricular tachycardias. Am J Cardiol 1966; 7:758-62
134. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 72-105, 202-37
135. Taylor P: Anticholinesterase agents, Goodman and Gilman's Pharmacologic Basis of Therapeutics, 9th ed. Edited by Hardman J, Limbird L. New York, McGraw-Hill, 1996, 161-76
136. Mudge G, Weiner I: Agents affecting volume and composition of body fluids, The Pharmacologic Basis of Therapeutics. 8th ed. Edited by Goodman A, Rall T, Nies A. New York, Pergammon Press, 1990, pp 682-707
137. McLean R: Magnesium and its therapeutic uses: A review. Am J Med 1994; 96:63-76
138. Zwerling H: Does exogenous magnesium suppress myocardial irritability and tachydysrhythmias in the nondigitalized patient? Am Heart J 1987; 113:1046-53
139. Iseri L, Freed J, Bures A: Magnesium deficiency and cardiac disorders. Am J Med 1975; 58:837-46
140. Iseri L, Chung P, Tobis J: Magnesium therapy for intractable ventricular tachvarrhythmias in normomagnesemic patients. West J Med 1983; 138:823-8
141. Bailie D, Inoue H, Kaseda S, Ben-David J, Zipes D: Magnesium suppression of early after depolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation 1988; 77:1395-402
142. Gettes L: Electrolyte abnormalities as triggers for lethal ventricular arrhythmias, Sudden Cardiac Death. Edited by Akhtar M, My- erburg R, Ruskin J. Philadelphia, Williams and Wilkins, 1994, pp 327-40
143. Kaseda S, Gilmour R, Zipes D: Depressant effect of magnesium on early after depolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyrdine in canine cardiac Purkinje fibers. Am Heart J 1989; 118:458-66
144. 14-1. Jackman W, Friday K, Anderson J, Aliot E, Clark M, Lazzara R: The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115-72
145. Tzivoni D, Banai S, Schuger C, Benhorin J, Kneren A, Gottlieb S, Stern S: Treatment of torsades de pointes with magnesium sulfate. Circulation 1988; 77:392-7
146. Tzivoni D, Keren A: Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990; 65:1397-9
147. Sueta C, Clarke S, Dunlap S, Jensen L, Blauwet M, Koch G, Patterson J, Adams K: Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation 1994; 89:660-6
148. Sugar P, Widerhorn J, Petersen R, Leon C, Ryzen E, Rude R, Rahimtoola S, Bhandari A: Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Am Heart J 1990; 119:308-16
149. Viskin S, Behassen B, Sheps D, Laniado S: Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate. Am J Cardiol 1992; 70:879-85
150. Wesley RJ, Haines D, Lerman B, DiMarco J, Crampton R: Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol 1989; 63:1129-31
151. Wistbacka J-OM, Koistinen J, Karlqvist K, Lepojarvi M, Hanhela R, Laurila J, Nissinen J, Pokela R, Salmela E, Puokonen A, Nuutinen L: Magnesium substitution in elective coronary artery surgery: A double-blind clinical study. J Cardiothor Vasc Anesth 1995; 9:140-6
152. Casthely P, Yoganathan T, Komer C, Kelly M: Magnesium and arrhythmias after coronary bypass surgery. J Cardiothor Vasc Anesth 1994; 8:188-91
153. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 177-201, 238-300
154. Atlee J: Perioperative Cardiac Dysrhythmias. Chicago, Year Book Medical Publishers, 1990, 231-5
155. Vitez T, Soper L, Wong K, Soper P: Chronic hypokalemia and intraoperative dysrhythmias. ANESTHESIOLOGY 1985; 63:130-3
156. Atlee J, Gombotz H, Tscheliessnigg K, eds: Perioperative Management of Pacemaker Patients. Berlin, Springer-Verlag, 1992. pp 1-155
157. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, 293-329
158. Waldo A, Wells J, Cooper T, MacLean W: Temporary cardiac pacing: Applications and techniques in the treatment of cardiac arrhythmias. Prog Cardiovasc Dis 1981; 23:451-74
159. Waldo A, Biblo L, Carlson M: Temporary pacing in diagnosis and treatment of arrhythmias after open-heart surgery, New Perspectives in Cardiac Pacing, vol 2. Edited by Barold S, Mugica J. Mt. Kisco, NY, Futura Publishing, 1991, pp 339-57
160. Luceri R, Stafford W, Castellanos A, Myerburg R: The temporary pacemaker, Management of Cardia Arrhythmias. Edited by Platia E. Philadelphia, JB Lippincott, 1987, pp 219-35
161. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, pp 247-92
162. Zoll P, Zoll R, Falk R, Clinton J, Eitel D, Antman E: External noninvasive temporary cardiac pacing: Clinical trials. Circulation 1985; 71:937-44
163. Altamura G, Toscano S, Bianconi L, Lo Bianco F, Montefoschi N, Pistolese M: Transcutaneous cardiac pacing: Evaluation of cardiac activation. PACE 1990; 13:2017-21
164. Bocka J: External transcutaneous pacemakers. Ann Intern Med 1989; 18:1280-6
165. Kelly J, Royster R: Noninvasive transcutaneous pacing. Anesth Analg 1989; 69:229-38
166. Syverud S, Dalsey W, Hedges J: Transcutaneous and transvenous cardiac pacing for early bradysystolic cardiac arrest. Ann Emerg Med 1986; 15:121-4
167. Konstadt S, Reich D, Thys D, Hillel Z, Louie E: Importance of atrial systole to ventricular filling predicted by transesophageal echocardiography. ANESTHESIOLOGY 1990; 72:971-6
168. Atlee J, Pattison C, Mathews E, Bilof R, Hedman A: Evaluation of transesophageal atrial pacing stethoscope in adult patients under general anesthesia. PACE 1992; 15:1515-25
169. Ellenbogen K, Kay G, Wilkoff B: Clinical Cardiac Pacing. Philadelphia, WB Saunders, 1995, pp 701-5
170. Andersen H, Pless P: Transesophageal pacing. PACE 1983; 6:674-9
171. Prochazek F, Jerzy G, Stopczyk M: A method of esophageal electrogram recording for diagnostic atrial and ventricular pacing. PACE 1990; 13:1136-41
172. Cochrane D, McEneaney D, Dempsey G, Anderson J, Adgey A: An esophageal and gastric approach to ventricular pacing. PACE 1995; 18:28-35
173. McKeown P, Croal S, Allen J, Anderson J, Adgey A: Transesophageal cardioversion. Am Heart J 1993; 125:396-404
174. Backofen J, Schauble J, Rogers M: Transesophageal pacing for bradycardia. ANESTHESIOLOGY 1984; 61:777-9
175. Buchanan D, Clements F, Reves J, Hochman H, Kates R: Atrial esophageal pacing in patients undergoing coronary artery bypass grafting: Effect of previous cardiac operations and body surface area. ANESTHESIOLOGY 1988; 69:595-8
176. Pattison C, Atlee J, Krebs L, Madireddi L, Kettler R: Transesophageal indirect atrial pacing for drug-resistant sinus bradycardia. ANESTHESIOLOGY 1991; 74:1141-4
177. Smith I, Monk T, White P: Comparison of transesophageal atrial pacing with anticholinergic drugs for the treatment of intraoperative bradycardia. Anesth Analg 1994; 78:245-52
178. Di Biase M, Rizzo U, Minafra F, Tritto M, Favale S, Rizzon P: Usefulness of transesophageal atrial pacing in hyperkalemia-induced impulse formation and conduction disturbances. Int J Cardiol 1989; 25:213-8
179. Dick MI, Scott M, Serwer J, Bromberg B, Beekman R, Rocchini A, Snider A, Crowley D, Rosenthal A: Acute termination of supraventricular tachyarrhythmias in children by transesophageal atrial pacing. Am J Cardiol 1988; 61:925-7
180. Falk R: Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter. Chest 1987; 92:110-4
181. Harte M, Teo K, Horgan J: The diagnosis and management of supraventricular tachycardia by transesophageal cardiac stimulation and recording Chest 1988; 93:339-44
182. Chung D, Kerr C, Cooper J: Termination of spontaneous atrial flutter by transesophageal pacing. PACE 1987; 10:1147-53
183. Crawford W, Plumb V, Epstein A: Prospective evaluation of transesophageal pacing for the interruption of atrial flutter. Am J Med 1989; 86:663-7
184. Guarnerio M, Furlanello F, Del Greco M, Vergara G, Inama G, Disertori M: Transesophageal atrial pacing: A first-choice technique in atrial flutter therapy. Am Heart J 1989; 117:1241-51
185. Kaneda S, Inoue T, Fukuzaki H: Treatment of atrial flutter and rapid atrial tachycardia with transesophageal atrial pacing. Jpn Heart J 1989; 30:-471-8
186. Barold S, Zipes D: Cardiac pacemakers and antiarrhythmic devices, Heart Disease, 4th ed. Edited by Braunwald E. Philadelphia, WB Saunders, 1992, pp 726-55
187. Atlee J: Cardiac pacing and electroversion, Cardiac Anesthesia, 3rd ed Edited by Kaplan J. Philadelphia, WB Saunders, 1995, pp 877-904
188. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, pp 205-16
189. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 412-24
190. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 225-45
191. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 752-67
192. Atlee J: Perioperative Cardiac Dysrhythmias. Chicago, Year Book Medical Publishers, 1990, pp 187-273, 373-424
193. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders, 1996, pp 59-104
194. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 116-32
195. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 768-89
196. Gillette P, Smith R, Garson AJ, Mullins C, Gutgesell H, Goh T-H, Cooley D, Mcnamara D: Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy. JAMA 1985; 253: 391-2
197. Mehta A, Sanchez G, Sacks E, Casta A, Dunn J, Donner R: Ectopic automatic atrial tachycardia in children: Clinical characteristics, management and follow-up. J Am Coll Cardiol 1988; 11:379-85
198. Naccarelli G, Shih H-T, Jalal S: Sinus node reentry and atrial tachycardias, Cardiac Electrophysiology, 2nd ed. Edited by Zipes D, Jalife J. Philadelphia, WB Saunders, 1995, pp 607-19
199. Dodo H, Gow R, Hamilton R, Freedom R: Chaotic atrial rhythm in children. Am Heart J 1995; 129:990-5
200. Kouvaras G, Cokkinos D, Halal G, Chronopoulas G, Ioannou N: The effective treatment of multifocal atrial tachycardia with amiodarone. Jpn Heart J 1989; 30:301-12
201. Zeevi B, Berant M, Sclarovsky S, Blieden L: Treatment of multifocal atrial tachycardia with amiodarone in a child with congenital heart disease. Am J Cardiol 1986; 57:344-5
202. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 201-17
203. Pick A, Dominguez P: Nonparoxysmal A-V nodal tachycardia. Circulation 1957; 16:1022-32
204. Solomon D, Rogers J: Esmolol for the treatment of isorhythmic atrioventricular dissociation. J Cardiothor Vasc Anesth 1992; 6:603-5
205. Ganz, L, Friedman P: Supraventricular tachycardia. N Engl J Med 1995; 332:162-73
206. Kastor J. Arrhythmias. Philadelphia, WB Saunders, 1994, pp 250-309
207. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 202-61
208. Wolff L, Parkinson J, White P: Bundle branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. Am Heart J 1930; 5:685-704
209. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 828-74
210. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 166-74
211. Conti J, Belardinelli L, Curtis A: Usefulness of adenosine in diagnosis of tachyarrhythmias. Am J Cardiol 1995; 75:952-5
212. Das G, Ferris J: Esmolol in the treatment of supraventricular tachyarrhythmias. Can J Cardiol 1988; 4:177-80
213. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach. Armonk, NY. Futura Publishing Co., Inc., 1994, pp 49-59
214. DiMarco J: Adenosine, Cardiac Electrophysiology, 2nd ed. Edited by Zipes D, Jalife J. Philadelphia, WB Saunders, 1995, pp 1336-44
215. Hood M, Smith W: Adenosine versus verapamil in the treatment of supraventricular tachycardia: A randomized double-crossover trial. Am Heart J 1992; 123:1543-9
216. Li H, Morillo C, Zardini M, Thakur R, Yee R, Klein G: Effect of adenosine
217. Mannino M, Mehta D, Gomes J: Current treatment options for paroxysmal supraventricular tachycardia. Am Heart J 1994; 127:475-80
218. Sharma A, Klein G, Yee R: Intravenous adenosine triphosphate during wide QRS tachycardia: Safety, therapeutic efficacy, and diagnostic utility. Am J Med 1990; 88:337-43
219. Gulamhusein S, Ko P, Carruthers S, Klein G: Acceleration of the ventricular response during atrial fibrillation in Wolff-Parkinson-White syndrome after verapamil. Circulation 1982; 65:348-54
220. Waugh R, Ramo B, Wagner G, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 202-37
221. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 105-15
222. Podrid P, Kowey P: Cardiac Arrhythtnia. Baltimore, Williams and Wilkins, 1995, pp 803-27
223. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 790-802
224. Davis W, Schaal S: Pharmacologic suppression of atrial flutter induced by atrial stimulation. Am Heart J 1995; 123:681-6
225. Ellenbogen K, Dias V, Cardello F, Dias V, Cardello F, Strauss W, Simonton C, Pollak S, Wood M, Stambler B: Safety and efficacy of intravenous diltiazen in atrial fibrillation or flutter. Am J Cardiol 1995; 75:45-9
226. Sung R, Tan H, Karagounis L, Hanyok J, Falk R, Platia E, Das G, Hardy S: Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study. Am Heart J 1995; 129:739-48
227. Nattel S: Newer developments in the management of atrial fibrillation. Am Heart J 1995; 130:1094-106
228. Lip G, Metcalfe M, Rae A: Management of paroxysmal atrial fibrillation. Quarterly J Med 1993; 86:467-72
229. Kannel W, Abbot R, Savage D, McNamara P: Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 1983; 106:389-96
230. Manning W, Silverman D, Oettgen P, Douglas P: Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5 year study. J Am Coll Cardiol 1995; 25: 1354-61
231. Kerin N, Faitel K, Naini M: The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Arch Intern Med 1996; 156:49-53
232. Chakko S, Kessler K: Recognition and management of cardiac arrhythmias. Curr Probl Cardiol 1995; 20:55-117
233. Goldenbcrg I, Lewis W, Dias V, Heywood J, Pedersen W: Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. Am J Cardiol 1994; 74:88-1-9
234. Shettiger U, Toole J, Appunn D: Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter. Am Heart J 1993; 126:368-74
235. Platia E: Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989; 63:925-9
236. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 310-35
237. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 891-918
238. Discher T, Kumar P: Pro: Antiarrhythmic drugs should be used to suppress ventricular ectopy in the perioperative period. J Cardiothorac Vasc Anesth 1994; 8:699-700
239. Miller S, Mayer R: Con: Antiarrhythmic drugs should not be used to suppress ventricular ectopy in the perioperative period. J Cardiothor Vasc Anesth 1994; 8:701-3
240. Lown B, Wolf M: Approaches to sudden death from coronary heart disease. Circulation 1971; 44:130-42
241. Atlee J: Arrhythmias and Pacemakers. Philadelphia, WB Saunders. 1996, pp 389-449
242. Griffith M, Garratt C, Rowland E, Ward D, Camm A: Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Am J Cardiol 1994; 73:759-64
243. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 310-35, 363-75
244. Waugh R, Wagner G, Ramo B, Gilbert M: Cardiac Arrhythmias. Philadelphia, FA Davis, 1994, pp 3-32
245. Podrid P, Kowey P: Cardiac Arrhythmia Baltimore, Williams and Wilkins, 1993, pp 907-35
246. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 201-217, 318, 345-6
247. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, 206-7
248. Podrid P, Kowey P: Cardiac Arrhythmia, Baltimore, Williams and Wilkins, 1995, 919-35
249. Cossu S, Buxton A: The clinical spectrum of ventricular tachyarrhythmias with coronary artery disease. Cardiol Rev 1995; 3:240-50
250. Hamdan M, Scheinman M: Uncommon forms of ventricular tachycardia. Cardiol Rev 1996; 4:13-24
251. Mont L, Sexias T, Brugada P, Brugada J, Simonis F, Kriek E, Smeets J, Wellens H: The elcctrocardiographic, clinical, and electrophysiologic spectrum of idiopathic monomorphic ventricular tachycardia. Am Heart J 1992; 124:746-53
252. Hunt G, Ross D: Comparison of the effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction, Circulation 1988; 78:221-6
253. Denniss A, Richards D, Taylor A, Urther J: Halothane anesthesia reduces inducibiltiy of ventricular tachyarrhythmias in chronic canine myocardial infarction. Bas Res Cardiol 1989; 84:5-12
254. Deutsch N, Hantler C, Tait A, Upritchard A, Schork M, Knight P: Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction. ANESTHESTOLOGY 1990; 72:1012-21
255. Gallagher JD, McCleman CA: The effects of halothane on ventricular tachycardia in intact dogs. ANESTHESIOLOGY 1991; 75:866-75
256. Cardinal R, Janse M, Van Eeden I, Werner G, D'aloncourt C, Durrer D: The effect of lidocaine on intracellular and extracellular potentials, activation and ventricular arrhythmias during acute regional ischemia in the isolated porcine heart. Circ Res 1981; 49:792-806
257. Callans D, Marchlinski F: Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: Evidence for a distinct mechanism, J Am Coll Cardiol 1992; 19:1111-7
258. Haverkamp W, Shenasa M, Borggrefe M, Breithardt G: Torsades de pointes, 2nd ed. Edited by Zipes DP, Jalife J. Philadelphia, WB Saunders, 1995, pp 865-99
259. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 376-94
260. Podrid P, Kowey P: Cardiac Arrhythmia, Baltimore, Williams and Wilkins, 1995, 936-63
261. Schwartz P, Locati E, Napolitano C, Priori S: The long QT syndrome, Cardiac Electrophysiology, 2nd ed. Edited by Zipes D, Jalife J. Philadelphia, WB Saunders, 1995, pp 788-811
262. Perticone F, Adinolfi L, Bonaduce D: Efficacy of magnesium sulfate in the treatment of torsades de pointes. Am Heart J 1986; 112:847-9
263. Laub G, Muralidharan S, Janeira L, Moore R, Clancy R, Adkins M, Fernandez J, Anderson W, McGrath L: Refractory postoperative torsades de pointes successfully treated with isoproterenol. J Cardiothorac Vasc Anesth 1993; 7:210-2
264. Moss A, Schwartz P, Crampton R, Tzivoni D, Locati E, MacCluer J, Hall W, Weitcamp L, Vincent G, Garson A, Pobinson J: The long QT syndrome: Prospective longitundinal study of 328 families. Circulation 1991; 84:1136-44
265. Shimizu W, Ohe T, Kurita T, Kawade M, Arakaki V, Aihara N, Kamakura S, Kamiya T: Effects of verapamil and propranolol on early after depolarizations and ventricular arrhythmias induced In epinephrine in congenital long QT syndrome. J Am Coll Cardiol 1995; 26:1299-309
266. Moss A, Zareba W, Benhorin J, Locati E, Hall W, Robinson J, schwartz P, Towbin J, Vincent G, Lehmann M, Keating M, MacCluer J, Tomothy K: ECG-T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92:2929-34
267. Schwartz P, Priori S, Locati, EH, Napolitano C, Cantu F, Towbib J, Keating M, Hammoude H, Brown A, Chen L, Colatsky T: Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na + channel blockade and to increases in heart rate. Circulation 1995; 92:3381-6
268. Rosen M: Long QT syndrome patients with gene mutations Circulation 1995; 92:3373-5
269. The Sicilian Gambit: Antiarrhythmic, Therapy: A Pathophysiologic Approach. Armonk, NY, Futura Publishing, 1994, pp 239-48, 251-63
270. Rodden D, Lazzara R, Rosen M, Schwartz P, Towbin J, Vincent M, for the SADS Foundation Task Force on LQTS: Multiple mechanisms in the long-QT syndrome. Circulation 1996; 94:1996-2012
271. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 395-420
272. Gomes J, Winters S, Ip J: Post infarction high risk of sudden death, Sudden Cardiac Death. Edited by Akhtar M, Myerburg R, Ruslin J. Philadelphia, Williams and Wilkins, 1994, pp 513-28
273. Manolio T, Furberg C: Epidemiology of sudden death, Sudden Cardiac Death. Edited by Akhtar M, Myerburg R, Ruskin J. Philadelphia, Williams and Wilkins, 1994, pp 3-20
274. Podrid P, Kowey P: Cardiac Arrhythmia, Baltimore, Williams and Wilkins, 1995, pp 964-1003
275. Epstein A, Ideker R: Ventricular fibrillation, Cardiac Electrophysiology, 2nd ed. Edited by Zipes D, Jalife J. Philadelphia, WB Saunders, 1995, pp 927-33
276. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, pp 974-1003
277. Black J, Barbey J, Echt D: Ventricular fibrillation affects defibrillation. J Am Coll Cardiol 1987; 9(suppl 2):142A
278. Winkle R, Mead R, Ruder M, Smith N, Buch W, Gaudiani V: Effect of the duration of ventricular fibrillation on defibrillation efficacy in humans. Circulation 1990; 81:1477-81
279. Niemann J, Cairns C, Sharma J, Lewis R: Treatment of pro- longed ventricular fibrillation: Immediate countershock versus highdose epinephrine and CPR preceding countershock. Circulation 1992; 85:281-1
280. Baum R, Alvarez H, Cobb L: Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 1974; 50:1231-5
281. Dreifus L, Fisch C, Griffin J, Gillette P, Mason J, Parsonnet V: Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices J Am Coll Cardiol 1991; 18:1-13
282. Kastor J: Arrhythmias. Philadelphia, WB Saunders, 1994, pp 145-200
283. Podrid P, Kowey P: Cardiac Arrhythmia. Baltimore, Williams and Wilkins, 1995, 1039-71
284. Kapur P, Campos J, Tippit S: Influence of diltiazen on on cardiovascular function and coronary hemodynamics during isoflurane anesthesia in the dog: Correlation with plasma diltiazem levels. Anesth Analg 1986; 65:81-7
285. Kapur P, Campos J, Buchca O: Plasma diltiazem levels, cardiovascular function, and coronary hemodynamics during enflurane anesthcsia in the dog. Anesth Analg 1986; 65:918-24
286. Kapur P, Matzrazzo D, Fung D, Sullivan K: The cardiovascular and adrenergic actions of verapamil or diltiazem in combination with propranolol during halothane anesthesia in the dog. ANESTHESIOLOGY 1987; 66:122-9
287. Rogers K, Hysing E, Merin R, Taylor A, Hartley C, Chelly J: Cardiovascular effects of interactions between calcium channel blocking drugs and anesthetics in chronically instrumented dogs. II. Verapamil, enflurane and isoflurane. ANESTHESIOLOGY 1964; 64:568-75
288. Foex P: Alpha- and beta-adrenoreceptor antagonists. Br J Anaesth 1984; 56:751-65
289. Kopriva C, Brown A, Pappas G: Hemodynamics during general anesthesia in patients receiving propranolol. ANESTHESIOLOGY 1978; 48:28-33
290. The Sicilian Gambit: Antiarrhythmic Therapy: A Pathophysiologic Approach. Armonk, NY, Futura Publishing, 1994:3-101